Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEDRAD is a global leader in medical devices and services that enhance diagnostic and therapeutic imaging procedures. The company specializes in contrast media injection systems, fluid disposal systems, and MR-compatible accessories for computed tomography (CT), magnetic resonance imaging (MRI), and cardiovascular applications. Founded in 1964 and now a key part of Bayer's Radiology business, MEDRAD's technology is designed to improve image quality and patient safety while streamlining clinical workflows. Their product portfolio includes well-known brands such as the Stellant and Spectris injection systems. The company also provides equipment service and support to healthcare facilities worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEDRAD.